Chargement en cours...
Rifaximin in the treatment of inflammatory bowel disease
The gut microbiota plays a role in promoting and maintaining inflammation in inflammatory bowel diseases (IBD), hence the rationale for the use of antibiotics in the treatment of those disorders. Antibiotics, however, may induce untoward effects, especially during long-term therapy. Rifaximin α poly...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2011
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3237300/ https://ncbi.nlm.nih.gov/pubmed/22180705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v17.i42.4643 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|